BioXp™ Genomic Workstation Makes European Debut at VIB Research Institute in Belgium

22 August 2017
SGI-DNA’s benchtop automated DNA printer to accelerate genomic research as part of VIB’s Technology Watch Initiative 

SGI-DNA Inc., a Synthetic Genomics Inc. (SGI) company, and VIB, a Belgian life science research institute, today announced that VIB will become the first institute in Europe to integrate the BioXp™ 3200 System in its workflows as part of its vision for adopting breakthrough technologies.  The BioXp™ 3200 System is the world’s first benchtop automated genomic workstation that rapidly prints high-quality, double-stranded DNA fragments and clones into any vector in an overnight run. With the BioXp™ 3200 System, VIB will be accelerating turnaround time for generating custom DNA for genomic research.

VIB’s Technology Watch Initiative implements new, emerging, and disruptive technologies into its laboratories and research facilities. Active since 2008, the Technology Watch program evaluates strategic technology investment opportunities and provides the funding to secure prototype instruments and early-stage technologies from high-potential fields such as Synthetic Biology, CRISPR, and single-cell analysis. The BioXp™ 3200 System will be placed in the lab of Thomas Jacobs, Ph.D., a VIB scientist in the VIB-UGent Center for Plant Systems Biology,  who is developing and optimizing plant genome editing through the use of CRISPR/Cas systems.

“The BioXp™ 3200 System will fundamentally change the way our research group approaches cloning. Not only will it greatly reduce our turnaround time for cloning projects, but also will hopefully open up new ways to test the gene editing systems we are developing,” says Dr. Jacobs.

“By automating rapid DNA synthesis, this will put VIB in a competitive position, allowing researchers to focus their time on the crucial scientific questions rather than on routine lab work,” adds Halina Novak, Ph.D., Technology Watch program manager at VIB.

Scientists are able to specifically design and clone genes with the BioXp™ System to answer key questions in their function  in biological systems. With the BioXp™ 3200 System, researchers do not need a template to obtain a gene of interest. Genes are built in silico, designed with sequence modifications to address the specific research.

“Automating gene synthesis promotes scientific discovery and advancement,” says Nathan Wood, president of SGI-DNA. “The global expansion of the BioXp™ 3200 System, notably to one of Europe’s most innovative research institutes, will help to facilitate further genomic breakthroughs in life science research.” 

More information is available at Sgidna


©VIB-Ine Dehandschutter